Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Avelumab

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1EMD Serono

    02 1EMD Serono, A Division of EMD Inc., Canada

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    EMD Serono

    Avelumab
    arrow
    Pharmaconex
    Not Confirmed

    EMD Serono

    Country
    arrow
    Pharmaconex
    Not Confirmed

    Patent Expiration Date : 2020-08-23

    Date Granted : 2011-02-15

    Avelumab

    Brand Name : BAVENCIO

    Patent Number : 2383424

    Filing Date : 2000-08-23

    Strength per Unit : 20 mg / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAVENOUS

    Patent Expiration Date : 2020-08-23

    Date Granted : 2011-02-15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    EMD Serono, A Division of EM...

    Avelumab
    arrow
    Pharmaconex
    Not Confirmed

    EMD Serono, A Division of EMD Inc., Canada

    Country
    arrow
    Pharmaconex
    Not Confirmed

    Patent Expiration Date : 2032-11-21

    Date Granted : 2021-10-26

    Avelumab

    Brand Name : BAVENCIO

    Patent Number : 2856895

    Filing Date : 2012-11-21

    Strength per Unit : 20 mg / mL

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : INTRAVENOUS

    Patent Expiration Date : 2032-11-21

    Date Granted : 2021-10-26

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF